title: 'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII.
abstract: Serological testing for anti-neural autoantibodies is important in patients presenting with idiopathic cerebellar ataxia, since these autoantibodies may indicate cancer, determine treatment and predict prognosis. While some of them target nuclear antigens present in all or most CNS neurons (e.g. anti-Hu, anti-Ri), others more specifically target antigens present in the cytoplasm or plasma membrane of Purkinje cells (PC). In this series of articles, we provide a detailed review of the clinical and paraclinical features, oncological, therapeutic and prognostic implications, pathogenetic relevance, and differential laboratory diagnosis of the 12 most common PC autoantibodies (often referred to as 'Medusa-head antibodies' due to their characteristic somatodendritic binding pattern when tested by immunohistochemistry). To assist immunologists and neurologists in diagnosing these disorders, typical high-resolution immunohistochemical images of all 12 reactivities are presented, diagnostic pitfalls discussed and all currently available assays reviewed. Of note, most of these antibodies target antigens involved in the mGluR1/calcium pathway essential for PC function and survival. Many of the antigens also play a role in spinocerebellar ataxia. Part 1 focuses on anti-metabotropic glutamate receptor 1-, anti-Homer protein homolog 3-, anti-Sj/inositol 1,4,5-trisphosphate receptor- and anti-carbonic anhydrase-related protein VIII-associated autoimmune cerebellar ataxia (ACA); part 2 covers anti-protein kinase C gamma-, anti-glutamate receptor delta-2-, anti-Ca/RhoGTPase-activating protein 26- and anti-voltage-gated calcium channel-associated ACA; and part 3 reviews the current knowledge on anti-Tr/delta notch-like epidermal growth factor-related receptor-, anti-Nb/AP3B2-, anti-Yo/cerebellar degeneration-related protein 2- and Purkinje cell antibody 2-associated ACA, discusses differential diagnostic aspects and provides a summary and outlook.
authors.affiliation: Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Otto Meyerhof Center, Im Neuenheimer Feld 350, D-69120, Heidelberg, Germany. sven.jarius@med.uni-heidelberg.de.
authors.forename: S
authors.initials: S
authors.lastname: Jarius
authors.affiliation: Molecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Otto Meyerhof Center, Im Neuenheimer Feld 350, D-69120, Heidelberg, Germany. brigitte.wildemann@med.uni-heidelberg.de.
authors.forename: B
authors.initials: B
authors.lastname: Wildemann
mesh_terms: D002352:Carrier Proteins / Q000276:immunology*; D002490:Central Nervous System / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D002524:Cerebellar Ataxia / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D000072233:Homer Scaffolding Proteins; D006801:Humans; D053496:Inositol 1,4,5-Trisphosphate Receptors / Q000276:immunology*; D009124:Muscle Proteins / Q000276:immunology*; D009687:Nuclear Proteins / Q000276:immunology*; D018094:Receptors, Metabotropic Glutamate / Q000276:immunology*; D012097:Repressor Proteins / Q000276:immunology*
chemical_list: C491304:ANKRD1 protein, human; D002352:Carrier Proteins; D000072233:Homer Scaffolding Proteins; C506926:ITPR1 protein, human; D053496:Inositol 1,4,5-Trisphosphate Receptors; D009124:Muscle Proteins; D009687:Nuclear Proteins; D018094:Receptors, Metabotropic Glutamate; D012097:Repressor Proteins; C104077:metabotropic glutamate receptor type 1